Tokyo, Japan

Yutaka Kondoh

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 9.6

ph-index = 4

Forward Citations = 63(Granted Patents)


Location History:

  • Tokyo, JP (2010 - 2015)
  • Chuo-ku, JP (2016)

Company Filing History:


Years Active: 2010-2016

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: Yutaka Kondoh: Innovator in Cancer Treatment

Introduction

Yutaka Kondoh is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of cancer treatment. With a total of seven patents to his name, he has focused on developing compounds that target specific mutations associated with various types of cancer. His work has the potential to improve treatment options for patients suffering from serious conditions.

Latest Patents

One of Yutaka Kondoh's latest patents is for a diamino heterocyclic carboxamide compound. This compound is useful as an inhibitor against the kinase activity of the EML4-ALK fusion protein. Through extensive research, he and his team discovered that these compounds exhibit inhibitory activity against this fusion protein, which is crucial in the development of certain cancers. The compounds can be utilized as a pharmaceutical composition for preventing and treating various forms of cancer, including lung cancer, non-small cell lung cancer, and small cell lung cancer.

Another notable patent is for a pyrazinecarboxamide compound. These compounds are designed to treat cancer in patients who express the EGFR T790M mutation. This innovation represents a significant advancement in targeted cancer therapies, offering hope to patients with specific genetic profiles.

Career Highlights

Throughout his career, Yutaka Kondoh has worked with reputable companies in the pharmaceutical industry, including Astellas Pharma GmbH and Kotobuki Pharmaceutical Co. Ltd. His experience in these organizations has allowed him to refine his research and development skills, contributing to his success as an inventor.

Collaborations

Yutaka has collaborated with notable colleagues, including Itsuro Shimada and Takahiro Matsuya. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in cancer treatment.

Conclusion

Yutaka Kondoh's work in developing innovative compounds for cancer treatment showcases his dedication to improving patient outcomes. His patents reflect a commitment to addressing critical health challenges through scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…